Lobbied Canada

Command Palette

Search for a command to run...

Kier Doyle

Parliamentary Assistant, House of Commons7 communications in the past year

Lobbied by

CANADIAN NURSES ASSOCIATION/ASSOCIATION DES INFIRMIERES ET INFIRMIERS DU CANADA(CNA)

2

Urging Immigration, Refugees and Citizenship Canada, in collaboration with Health Canada, to reconsider introducing copayments for medications and supplemental health services under the Interim Federal Health Program (IFHP) for refugees and asylum seekers. Pandemic Planning: ensure all nurses are properly supported and protected by maintaining appropriate stockpiles of personal protective equipment (PPE), providing mental health supports for those working on the front lines, and ensuring nursing students receive adequate assistance. Increase access to education and training for nurses returning to work or working across various care settings during public health emergencies. Ensure clear guidelines and resources are developed and disseminated, and that senior nurses are included in discussions and advisory boards during emergency planning phases as well as in post-emergency reviews. Discussions aim to ensure that artificial intelligence and emerging health technologies are developed, assessed, and approved in ways that meet the needs of the Canadian population. Communications emphasize the importance of integrating nursing perspectives into governance, regulation, clinical and ethical evaluation, and approval processes for new technologies. Communications relate to ongoing efforts to strengthen the collection, harmonization, and use of nursing workforce data at the pan-Canadian level. Discussions include modelling future health and workforce needs, supporting evidence-based health human resource planning, and investing in robust data systems to inform public policy and decision-making. Discussions include a request for federal funding to support the organization of CNA's 2026 national conference, which will bring together nursing leaders, health system partners, and policy-makers to advance dialogue on workforce priorities, innovation, public health, and health system transformation. Communications address the need for federal investment in strategies to improve retention of nursing professionals, including support for mental health and well-being, improved working conditions, continuing professional development, and initiatives to reduce burnout and strengthen workforce stability across all regions of Canada. Discussions focus on measures to expand the capacity to educate and support Indigenous nurses across Canada, including targeted investments in nursing education programs, partnerships with Indigenous and community-based institutions, and initiatives that improve access, retention, and graduation outcomes for Indigenous nursing students. Support the development of a national licensure framework for nurses. Enhance nursing leadership at the federal level and ensure ongoing support, resources, and sustainability for Chief Nursing Officer roles in all provinces and territories. Communications relate to federal measures aimed at protecting health-care workers, including initiatives to improve workplace safety, prevent harassment and violence, and strengthen legislative and regulatory frameworks that support a safe and respectful environment for health professionals. Bill S-233, An Act to amend the Criminal Code (assault against persons who provide health services and first responders) Harmonize nursing regulatory practices to support a responsive and sustainable nursing workforce Support a Canadian Nurse Practitioner Initiative based on past similar initiatives Allow nurses to certify the Disability Tax Credit form Seek funding for nursing research, including Indigenous nursing Create a pan-Canadian health human resources strategy Urging the federal government to lead the development of and work with the provinces and territories to implement a pan-Canadian digital health strategy. That the federal government lead efforts to educate health-care workers on the importance of medication safety and deprescribing Support for regulated nurses working at full scope of practice Strengthening of programs and supports for vulnerable po

Dairy Farmers of Manitoba

2

Legislative proposals, bills, and/or resolutions that impact dairy farmers in Manitoba. Regulations relating to compositional standards of dairy products, and those that have impacts on dairy farmers. Promote and defend Canada's supply management system as it relates to trade agreements, bilateral and multilateral negotiations, industry research, and policy changes.

The Association of Faculties of Medicine of Canada

2

AFMC, with its partners, is advocating for changes to Canadian policies (tax and intellectual property) to encourage private sector investment in health and biomedical research, as well as initiatives promoting planetary health. The AFMC calls on the federal government to support the sciences and innovation in health research by making how best to train and sustain Canada's future physician-scientist a key part of the discussions surrounding the new Health Accord AFMC seeks increased funding to enhance educational programming relating to professionalism, aboriginal health needs, public health, end-of-life/palliative care and Francophone minorities projects. AFMC is advocating for programs aimed at helping manage physician workforce issues through specific initiatives in medical education, allocation of residency positions and policies regarding international medical graduates. AFMC is advocating for enhancements and optimization of Canada's health and biomedical research enterprise, focussing specifically on issues relating to clinical trials.

Canadian Civil Liberties Association

1

Introduction to the Canadian Civil Liberties Association Meet with new senior officials to provide an introduction to CCLA staff, activities and priorites Bill C-36, An Act to enact the Protecting Privacy and Consumer Data Act, respecting the need to include robust restrictions on private-sector handling of personal data and on the adoption and use of artificial intelligence tools to ensure protection of privacy and human rights. Bill C-34, An Act to enact the Digital Safety Act and the Digital Safety Commission of Canada Act, with respect to state-compelled limitations on free speech on social media, generative AI, and other online services, imposition of age verification requirements onto various online services, and compliance of the proposal with freedom of expression and privacy rights. Bill C-2, An Act respecting certain measures relating to the security of the border between Canada and the United States and respecting other related security measures, with respect to legal standards for peace officers/CSIS to obtain information, a proposed regime to require surveillance-enabled digital services, cross-border information sharing (which are also replicated in Bill C-22, An Act respecting lawful access), and amendments to IRPA that would impact refugee protection and permit categorical cancellation of documents, and which are also replicated in Bill C-12, An Act respecting certain measures relating to the security of Canada’s borders and the integrity of the Canadian immigration system and respecting other related security measures. The federal government's adoption of a public registry for its use of artificial intelligence tools, and how to improve the utility of this registry as a government accountability tool. Bill C-4, An Act respecting certain affordability measures for Canadians and another measure, and Bill C-25, An Act respecting the Canada Elections Act and to enact An Act to change the names of certain electoral districts, 2026 with respect to the information privacy framework applicable to federal political parties. Bill C-8, An Act respecting cybersecurity, amending the Telecommunications Act and making consequential amendments to other Acts. Lobbying around telecommunications and cybersecurity, with an intention of making proposed legislation more respecting of privacy and human rights. Bill C-15, An Act to implement certain provisions of the budget tabled in Parliament on November 4, 2025, and concerns regarding Part 5, Division 5, of that Bill and its proposed introduction of a "Henry the VIII" clause that would empower the government to exempt private and public entities from the application of federal laws. Bill C-16, Protecting Victims Act. Charter and civil liberties concerns about the legislation, particularly in relation to impact on s. 11(b) of the Charter. Bill C-9, An Act to amend the Criminal Code (hate propaganda, hate crime and access to religious or cultural places), and specifically that its new anti-protests provisions risk criminalizing peaceful protestors; its problematic removal of Attorney General consent requirement for hate propaganda charges; that its new standalone hate crime offence is unduly stigmatizing and paves the way to excessive sentences; that its proposed definition of hatred does not align with Supreme Court of Canada precedents; and concerns regarding the addition of a "promotion of terrorism" offence. The civil liberties implications of forced detox under the Protective Detention and Care of Intoxicated Persons Act, SM 2025, c 49. Consultation on prospective amendments to the Criminal Code related to offences against children. Prospective amendments to the Criminal Code related to mandatory minimum sentences and remedies for violations of s. 11(b) of the Charter. Bill S-209, An Act to restrict young persons’ online access to pornographic material, regarding the privacy implications of a proposed age verification requirement that would be imposed by the Bill on online enti

Canadian Medical Association

1

HEALTH DATA INTEROPERBILITY: Provide CMA’s perspective as it relates to health data interoperability that would ensure providers have access to the right information at the right time when providing care, and improve patient outcomes and their health care experience. BUDGET: Provide CMA’s perspective on the Government of Canada’s budget, particularly as it relates to modernizing Canada’s health care system by enhancing efficiency, driving innovation, and promoting equitable access to care. HARMFUL ONLINE CONTENT: Advocate to address the escalation of online harassment, intimidation, and threats of violence targeting physicians, other health workers, and anyone seeking health care treatment, including measures to strengthen the Criminal Code of Canada and the Canadian Human Rights Act. TECHNOLOGY AND ARTIFICIAL INTELLIGENCE: provide CMA’s perspective on the impact of technology and artificial intelligence on the health care sector and the means through which advancements can be foreseen and managed. HEALTH PROMOTION AND DISEASE PREVENTION: Increased investments in health and social-determinants-of-health related programs, including measures to address the opioid crisis, mental health and addictions, and the regulation of natural health products. ADMINISTRATIVE BURDEN: Advocate for measures to alleviate the administrative burden on physicians and support their professional wellbeing, including investment to facilitate the development of EHRs and EMRs in Canada, improved remuneration for the completion of federal health forms, the development of a Federal Disability Benefit, ensuring that physicians are not captured in the definition of "promoters" in the Disability Tax Credit Promoters Restrictions Regulations, providing clarity and guidance on federal forms, and advocacy on discontinuing the requirement that employees present sick notes to their employers. The CMA is advocating that the trade of medical goods and medications be protected to avoid disruptions to patient care. Specifically, that the government: Continue to ensure pharmaceutical products and medical devices are not included in any countermeasures on tariffs. Improve safeguards for Canadian health data. Improve labour mobility so physicians can work across the country. Make it easier for qualified physicians to immigrate and work in Canada, including by fast-tracking immigration steps for US physicians. PAN CANADIAN LICENSURE: Advocate for the ability for physicians with full licences to practise independently without restrictions or for medical resident trainees registered in any Canadian jurisdiction to practise or train in any other Canadian jurisdiction without having to acquire more than one licence or pay additional licensing fees. This includes exploring enabling legislation in the provinces and territories. INTEGRATED HEALTH HUMAN RESOURCES Advocate for an Integrated Health Human Resources Strategy, including creating retention incentives and addressing administrative burden for health care professionals, increasing the number of doctors and nurses and ensuring that every Canadian has access to a family doctor or primary health team, increasing access to virtual care, creating an action plan to get internationally trained health care professionals to work, improving workforce data collection across health systems and investing in a supply needs-based planning tool, and facilitating team-based health care. MEDICAL MIS/DISINFORMATION: Provide CMA’s perspective on the impacts of medical misinformation and disinformation, including on public trust in science, medicine, and public health experts. INDIGENOUS HEALTH: Improvement to the health and health care services provided to Indigenous peoples in Canada including adding inclusive lettering on health cards across Canada. Advocating for the creation of a national Chief Health Accountability Officer. PUBLIC-PRIVATE HEALTHCARE: The CMA is conducting a series of in-person sessions across the country to engage key s

GlaxoSmithKline

1

Engagement with the Government regarding the Life Science Fund seeking partnership and funding to support completion of Phase I and Phase II clinical research program associated to AMR (antimicrobial resistance) Antimicrobial Resistance (AMR) - Seek funding and support for pilot projects making anti-infective medications available to equity seeking populations, helping to combat AMR. Also discuss any applicable conditions regarding this funding. Programs and policy to support Canadian biomanufacturing and access to medicines and vaccines for Canadians. National Immunization Strategy and policies and programs that impact public access to vaccines and disease prevention in Canada. Patented Medicines Review Board (PMPRB), certified under the Patent Act and whose guidelines seek to ensure a balance between the prices set by manufacturers for patented medicines sold in Canada and the maintenance of an attractive environment for pharmaceutical research and development. Engagement with federal officials regarding the Biomanufacturing & Life Sciences Strategy and policies and programming related to biomanufacturing in Canada Access to medicines - government policies, processes, legislation, and/or regulation with potential impact on access to medicines in Canada. Trade-related matters, including policies and tariffs impacting medicines and vaccines. Policies and programs related to the health of new immigrants to Canada. Policies, programs, and funding related to Canada's Sexually Transmitted and Blood-Borne Infections (STBBI) Action Plan 2024-2030. Engagement with federal officials regarding Health Emergency Readiness Canada. The National Pharmaceutical Strategy (NPS) as agreed by First Ministers in 2004. Advocacy for ways to increase access to medicines and vaccines for Canadian patients. The Common Drug Review (CDR) process for reviewing new drugs and providing listing recommendations to publicly funded drug benefit plans in Canada. Ensuring the access needs of Canadian patients are met by advocating on activities undertaken in the context of the CDR. Science and Technology (S&T) Strategy: Mobilizing Science and Technology to Canada's Advantage. Advocacy for measures which will allow for commercialization in health care to occur and for Canada to remain competitive internationally on Intellectual Property and other fronts. Public Services and Procurement Canada (PSPC) Integrity Framework - Clarifying the process for procurement of vaccines and possibly pharmaceuticals under the evolving procurement framework. Patented Medicines (Notice of Compliance) Regulations which seek to balance the protection of Intellectual Property (IP) and patents with cost containment. Advocacy to ensure that IP rights are respected and internationally competitive in order to promote Research and Development. Legislation, regulations, policies and programs concerning the federal government's response to COVID-19, including pandemic preparedness, pharmaceutical and vaccine supply-chain management, and general administration of justice. Food and Drugs Act and the bill formerly known as Bill C-51: An Act to amend the Food and Drugs Act and to make consequential amendments to other Acts. Specifically, with respect to the renewal of the drug approval process. Advocacy to ensure that Canada's review and approval process is timely, safe, effective, competitive and consistent with other jurisdictions. FedDev Ontario Advanced Manufacturing Fund - advancing manufacturing of innovative pharmaceutical products in southern Ontario Engage with government to strengthen the Priority Review for Drug Submissions process. Engage the Government regarding the need for clear and efficient procurement processes for COVID-19 medical countermeasures, including COVID-19 therapeutics, to ensure access for Canadians. Engagement with the Government regarding the Strategic Innovation Fund Drug Re-importation - Raise awareness regarding the potential risks to drug and vaccine supply fo

HealthCareCAN

1

Strengthening Canada’s health workforce including promoting health workforce safety. Advancing adoption of AI in the healthcare and health research sectors. Improving Canada’s physical and digital infrastructure for both health research and healthcare delivery. Federal role in the health system as it relates to funding, the use of federal spending power, and pan-Canadian priorities, including in the areas of aging, older adult care, child and youth health, mental health and substance use, palliative care, Indigenous health, public health, and data. Advancing Canada’s health research and innovation agenda as it relates to funding, policy and program design, and regulatory matters, including in the areas of clinical trials and development of innovative medical treatments.

Restaurant Brands International

1

Engaging on government policies and programs that improve the competitiveness of Canadian small and medium-sized enterprises (SMEs) and the restaurant sector, drive more investments directly in local communities and economies, and strengthen Canada's agri-food supply chain capacity.

Western Copper and Gold

1

Western Copper and Gold is seeking permission to construct, operate, close and reclaim the Casino mine in the Yukon to help support Canada’s transition to the green economy. As part of our work with the Yukon Government, we are engaging the broader public in addition to Federal, Territorial and First Nation governments.